Modular Medical Inc (MODD): Kapitalisasi marang pendapatan

Simbol lan logo merek Modular Med (MODD)

Direct shipments of insulin pumps to patients optimize costs, establishing a positive trajectory for Modular Medical (MODD). The revenue multiple confirms the strength of the trend, with the current level sitting around . Capitalization growth is driven by scaling sales and insurance reimbursements, while assembly diversification and electronic warehouse reserves ensure business resilience against supply chain disruptions.

MODD Multiplikator P/S Modular Med (04.07.2022 - 13.11.2026)

Rincian analitis perusahaan Modular Medical (MODD)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:MODD Modular Medical Inc
Barang utama Modular Medical, Inc.

Identifying assets with a high margin of safety requires analyzing market value relative to actual revenues. This ratio determines the price of each unit of revenue, allowing for an assessment of the premium paid for current sales volumes. For Modular Medical (MODD), this parameter reflects market expectations regarding the approval of new devices against the backdrop of electronics supply risks. The price action of the P/S multiple helps identify a dangerous disconnect between capitalization and actual demand in a timely manner.

Pesaing Modular Medical

BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Rasio kapitalisasi marang pendapatan|NSPR: Kapitalisasi marang pendapatan|Jin Medical International - Kapitalisasi marang volume dodolan|vivani.com (VANI) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan Xtant Medical|Rasio rega marang pendapatan NeuroOne Medical Technologies Corporation|Rega marang dodolan Myomo Inc. MYO|Multiplikator P/S COCH|Vivos Therapeutics Inc - Rasio kapitalisasi marang pendapatan|enVVeno Medical - Kapitalisasi marang pendapatan|Multiplikator P/S Sintx Technologies Inc SINT|TNON - Rasio rega marang pendapatan|LFWD: Rasio rega marang pendapatan|AMIX: Multiplikator P/S|INVO Fertility Corp (IVF) - Multiplikator P/S|Rasio rega marang pendapatan Bone Biologics|AXNX: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan BIOL (BIOLASE)|DYNT (dynatronics.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Paragon 28 FNA|INVO - Kapitalisasi marang pendapatan